EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.1 | alcohol dehydrogenase |
ovary |
- |
285604, 722337 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
ovary |
mRNA expression |
692959 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
ovary |
- |
725814 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
ovary |
low enzyme expression level |
669380 |
1.1.1.145 | 3beta-hydroxy-DELTA5-steroid dehydrogenase |
ovary |
- |
389376, 389395, 389397, 670037, 763397 |
1.1.1.145 | 3beta-hydroxy-DELTA5-steroid dehydrogenase |
ovary |
3beta-HSD II |
389387, 389395 |
1.1.1.145 | 3beta-hydroxy-DELTA5-steroid dehydrogenase |
ovary |
3beta-HSD21 is selectively expressed in adrenal glands and ovaries |
763397 |
1.1.1.145 | 3beta-hydroxy-DELTA5-steroid dehydrogenase |
ovary |
3betaHSD I |
389383 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
ovary |
- |
668432, 760868 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
ovary |
- |
-, 285978, 285980, 285982, 285983, 285984, 285985, 285992, 285993, 286001, 688136, 699835, 725822, 737453, 739860, 740126 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
ovary |
corpus luteum |
286000, 286002 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
ovary |
high expression level |
-, 668428, 670272 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
ovary |
immunohistochemical analysis shows that bovine 20alpha-HSD protein is intensively localized in the large luteal cells during the late estrous cycle |
726471 |
1.1.1.184 | carbonyl reductase (NADPH) |
ovary |
- |
285938, 688959, 697262 |
1.1.1.184 | carbonyl reductase (NADPH) |
ovary |
lower expression in prostate and testis than in ovary |
688959 |
1.1.1.188 | prostaglandin-F synthase |
ovary |
- |
-, 690009 |
1.1.1.188 | prostaglandin-F synthase |
ovary |
abundant expression |
760437 |
1.1.1.188 | prostaglandin-F synthase |
ovary |
high activity |
687797 |
1.1.1.189 | prostaglandin-E2 9-reductase |
ovary |
- |
389447, 389471 |
1.1.1.205 | IMP dehydrogenase |
ovary |
- |
347910 |
1.1.1.209 | 3(or 17)alpha-hydroxysteroid dehydrogenase |
ovary |
- |
-, 741315 |
1.1.1.21 | aldose reductase |
ovary |
- |
697266 |
1.1.1.239 | 3alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) |
ovary |
- |
287212, 712571 |
1.1.1.27 | L-lactate dehydrogenase |
ovary |
- |
683562 |
1.1.1.300 | NADP-retinol dehydrogenase |
ovary |
moderate expression level |
686690 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
ovary |
25% mRNA expression of Rdh5 compared to liver |
690797 |
1.1.1.34 | hydroxymethylglutaryl-CoA reductase (NADPH) |
ovary |
low expression level |
722328 |
1.1.1.36 | acetoacetyl-CoA reductase |
ovary |
low expression of isozymes AKR1B15.1 and AKR1B15.2 |
740743 |
1.1.1.42 | isocitrate dehydrogenase (NADP+) |
ovary |
- |
286812 |
1.1.1.47 | glucose 1-dehydrogenase [NAD(P)+] |
ovary |
- |
712633 |
1.1.1.50 | 3alpha-hydroxysteroid 3-dehydrogenase (Si-specific) |
ovary |
- |
389530, 389547 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
ovary |
- |
670037, 677079, 740637 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
ovary |
highest enzyme expression in female ovaries |
669905 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
ovary |
isozyme 17beta-HSD1, predominantly |
675476 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
ovary |
the enzyme is primarily expressed in the placenta and ovarian granulose cells |
761067 |
1.1.1.53 | 3alpha(or 20beta)-hydroxysteroid dehydrogenase |
ovary |
- |
287104, 287107, 287111, 668684, 688455 |
1.1.1.53 | 3alpha(or 20beta)-hydroxysteroid dehydrogenase |
ovary |
at late vitellogenesis stage, moderate expression of subunit A, highest expression of subunit B |
762606 |
1.1.1.53 | 3alpha(or 20beta)-hydroxysteroid dehydrogenase |
ovary |
at the late vitellogenesis stage, high expression of subunit A. Highest expression of subunit B is observed in ovary at late vitellogenesis stage |
762606 |
1.1.1.53 | 3alpha(or 20beta)-hydroxysteroid dehydrogenase |
ovary |
expressed in follicle cells |
655669 |
1.1.1.53 | 3alpha(or 20beta)-hydroxysteroid dehydrogenase |
ovary |
expression in ovarian follicles is low from day 0 to day 8 after spawning and is not detectable on day 11. Distinct expression is evident at day 14, the day of spawning |
654932 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
- |
287185, 287201, 656578, 656645, 686263, 688956, 740542, 762074 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
17beta-HSD8 in cumulus cells, not in granulosa and luteal cells, vice versa for isozymes 17beta-HSD1 and 17beta-HSD7 |
675983 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
enzyme type 2 from ovarian tumors: OVCAR-3, CAOV-3 |
287195 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
isozyme 17beta-HSD1 |
675982 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
low expression of isozymes AKR1B15.1 and AKR1B15.2 |
740743 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
low mRNA expression |
688007 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
moderate expression |
685803 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
ovarian surface epithelial cell |
670289 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
the enzyme is primarily expressed in the placenta and ovarian granulose cells |
761067 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
type 12 17beta-hydroxysteroid dehydrogenase is most highly expressed in ovary and mammary gland |
670273 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
ovary |
type 7 17beta-hydroxysteroid dehydrogenase is restricted to corpus luteum cells |
670031 |
1.1.1.64 | testosterone 17beta-dehydrogenase (NADP+) |
ovary |
- |
287225, 712571 |
1.1.1.64 | testosterone 17beta-dehydrogenase (NADP+) |
ovary |
isozyme 17beta-HSD1 |
675982 |
1.1.1.95 | phosphoglycerate dehydrogenase |
ovary |
- |
287528 |
1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (NAD+) |
ovary |
- |
285953 |
1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (NAD+) |
ovary |
low level of expression and activity |
695148 |
1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (NAD+) |
ovary |
surface epithelium |
670896 |
1.1.3.16 | ecdysone oxidase |
ovary |
- |
763342 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
ovary |
the high NQO2 activity of intraperitoneal ovarian metastases relative to other tissues indicates a potential for tretazicar therapy in the treatment of this disease |
686136 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
ovary |
- |
674370 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
ovary |
Gpx4 is found inside the ovary in the corpus luteum, stroma, follicles, and blood vessels |
764923 |
1.11.1.20 | prostamide/prostaglandin F2alpha synthase |
ovary |
- |
687797 |
1.11.1.20 | prostamide/prostaglandin F2alpha synthase |
ovary |
activity is the highest in spinal cord and brain followed by thymus, adrenal gland, heart, and genital organs |
687797 |
1.11.1.24 | thioredoxin-dependent peroxiredoxin |
ovary |
- |
725050 |
1.11.1.24 | thioredoxin-dependent peroxiredoxin |
ovary |
high expression |
758146 |
1.11.1.6 | catalase |
ovary |
- |
725932 |
1.11.1.9 | glutathione peroxidase |
ovary |
- |
725051 |
1.11.1.9 | glutathione peroxidase |
ovary |
extremely highly expressed in ovary |
725049 |
1.11.1.9 | glutathione peroxidase |
ovary |
highest mRNA expression in ovary, followed by pyloric caeca, heart, liver and brain |
724102 |
1.11.1.9 | glutathione peroxidase |
ovary |
specifically expressed in shrimp ovaries, but not in other tissues |
697467 |
1.13.11.31 | arachidonate 12-lipoxygenase |
ovary |
expression is dependent on differentiation of the ovary |
395424 |
1.13.11.33 | arachidonate 15-lipoxygenase |
ovary |
- |
639264 |
1.13.11.51 | 9-cis-epoxycarotenoid dioxygenase |
ovary |
in developing ovary |
676676 |
1.13.11.52 | indoleamine 2,3-dioxygenase |
ovary |
- |
764688 |
1.13.11.63 | beta-carotene 15,15'-dioxygenase |
ovary |
- |
713952, 728342 |
1.13.11.63 | beta-carotene 15,15'-dioxygenase |
ovary |
low levels of BCO mRNA |
438228 |
1.14.11.16 | peptide-aspartate beta-dioxygenase |
ovary |
- |
439251 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
ovary |
- |
724792 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
ovary |
high expression of lysine hydroxylase 3 |
724792 |
1.14.11.51 | DNA N6-methyladenine demethylase |
ovary |
- |
738025 |
1.14.11.53 | mRNA N6-methyladenine demethylase |
ovary |
- |
742336 |
1.14.11.53 | mRNA N6-methyladenine demethylase |
ovary |
m6A demethylase FTO is downregulated and N6-methyladenosine increases in granulosa cells of human aged ovaries |
764437 |
1.14.11.65 | [histone H3]-dimethyl-L-lysine9 demethylase |
ovary |
- |
-, 745102 |
1.14.11.66 | [histone H3]-trimethyl-L-lysine9 demethylase |
ovary |
- |
-, 745102 |
1.14.11.67 | [histone H3]-trimethyl-L-lysine4 demethylase |
ovary |
- |
753349 |
1.14.11.67 | [histone H3]-trimethyl-L-lysine4 demethylase |
ovary |
cellular and follicular stage-specific patterns of histone H3 methylation at lysine 4 in porcine preovulatory follicles and during luteinization in pig ovaries, overview. LSD1/KDM1 expression is restricted to the corpus luteum. While granulosa cells of primary, secondary, and early antral follicles are negative for H3-K4 methylation those from large antral follicles show a striking upregulation in the cells located in the proximity to the oocyte |
690008 |
1.14.13.9 | kynurenine 3-monooxygenase |
ovary |
- |
348523 |
1.14.14.1 | unspecific monooxygenase |
ovary |
predominantly, 17times higher expression than in testis |
698017 |
1.14.14.127 | methyl farnesoate epoxidase |
ovary |
of workers and reproducing queens, high MFE expression in ovaries of bumblebee females |
744987 |
1.14.14.14 | aromatase |
ovary |
- |
724244, 744946 |
1.14.14.14 | aromatase |
ovary |
activity is found only during vitellogenesis. At the completion of vitellogenesis, ovarian aromatase activity declines sharply resulting in elevation of plasma testosterone levels |
745062 |
1.14.14.14 | aromatase |
ovary |
highest signal intensity |
745022 |
1.14.14.14 | aromatase |
ovary |
increases in aromatase activities of the ovary and testis precede the onset of the ovarian and testicular development. Aromatase activities reach the highest level at the growing stage in February and the mature stage in March, and show a striking decrease at the spawning stage in April. Contents of ovarian and testicular estradiol-17beta change similarly to the profile of aromatase activities in the ovary and testis, although estrone shows no change |
724783 |
1.14.14.14 | aromatase |
ovary |
maternal ovaries and adrenals maintain high aromatase activity throughout gestation |
745021 |
1.14.14.14 | aromatase |
ovary |
ovarian aromatase activity is significantly decreased by treatments with estradiol or ethynylestradiol |
744150 |
1.14.14.154 | sterol 14alpha-demethylase |
ovary |
- |
671727, 673147 |
1.14.14.19 | steroid 17alpha-monooxygenase |
ovary |
- |
687964, 705401, 706689, 727561 |
1.14.14.19 | steroid 17alpha-monooxygenase |
ovary |
expression in ovary during gonad development |
703775 |
1.14.14.19 | steroid 17alpha-monooxygenase |
ovary |
theca-interstitial cell |
390130 |
1.14.14.29 | 25/26-hydroxycholesterol 7alpha-hydroxylase |
ovary |
- |
659660 |